Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05880888 · ClinicalTrials.gov registry record · Phase 1
Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment
A Phase 1 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT05880888 is a Phase 1 study that has completed, run by Ohio State University. The registered enrollment target is 3 participants.
The verdict
NCT05880888, a Phase 1 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is to assess the effect of Renuva® on fat pad regeneration in patients with Fat pad Impingement
Interventions
- BIOLOGICAL Renuva
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2023-04-22 |
| Est. Completion | 2025-02-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05880888
The ClinicalTrials.gov registry entry for NCT05880888 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Renuva is the first listed.
NCT05880888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05880888 about?
NCT05880888 is a clinical study titled "Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment". This study is to assess the effect of Renuva® on fat pad regeneration in patients with Fat pad Impingement
What is the current status of trial NCT05880888?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2023-04-22. Estimated completion is 2025-02-04.
What interventions are being tested in trial NCT05880888?
The interventions under investigation include: Renuva (BIOLOGICAL).
Who is sponsoring clinical trial NCT05880888?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.